-
Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice.
J Immunol. 1998 Feb 15;160(4):1687-93
PMID: 9469425
-
Antigen-specific, CD4+CD25+ regulatory T cell clones induced in Peyer's patches.
Int Immunol. 2003 Apr;15(4):525-34
PMID: 12663682
-
CD4+ T cells anergized by high dose feeding establish oral tolerance to antibody responses when transferred in SCID and nude mice.
J Immunol. 1995 Jun 15;154(12):6238-45
PMID: 7759861
-
Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells.
J Immunol. 2004 Jul 15;173(2):1043-50
PMID: 15240692
-
CD1-dependent dendritic cell instruction.
Nat Immunol. 2002 Dec;3(12):1163-8
PMID: 12415264
-
NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production.
J Exp Med. 2005 Jan 3;201(1):41-7
PMID: 15630137
-
Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
J Immunol. 2001 Oct 15;167(8):4245-53
PMID: 11591746
-
Antigen-specific T cell activation and proliferation during oral tolerance induction.
J Immunol. 1999 May 15;162(10):5868-75
PMID: 10229822
-
Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
J Exp Med. 2000 Oct 2;192(7):921-30
PMID: 11015434
-
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
Science. 1997 Nov 28;278(5343):1626-9
PMID: 9374463
-
Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
J Exp Med. 1992 Nov 1;176(5):1355-64
PMID: 1383385
-
Cross-presentation of disialoganglioside GD3 to natural killer T cells.
J Exp Med. 2003 Jul 7;198(1):173-81
PMID: 12847141
-
Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.
J Exp Med. 2001 Dec 17;194(12):1801-11
PMID: 11748281
-
Peripheral deletion of antigen-reactive T cells in oral tolerance.
Nature. 1995 Jul 13;376(6536):177-80
PMID: 7603570
-
Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13838-43
PMID: 11707602
-
Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
J Immunol. 1995 Jul 15;155(2):910-6
PMID: 7541826
-
alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8461-6
PMID: 10900007
-
NKT cells are dispensable in the induction of oral tolerance but are indispensable in the abrogation of oral tolerance by prostaglandin E.
Eur J Immunol. 2003 Jan;33(1):183-93
PMID: 12594847
-
NKT cell ligand alpha-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation.
Eur J Immunol. 2004 Sep;34(9):2471-9
PMID: 15307179
-
Role of NK1.1+ and AsGm-1+ cells in oral immunoregulation of experimental colitis.
Inflamm Bowel Dis. 2003 Mar;9(2):75-86
PMID: 12769441
-
Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.
Immunol Rev. 2001 Aug;182:207-14
PMID: 11722636
-
Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.
Science. 1997 Nov 28;278(5343):1623-6
PMID: 9374462
-
Orally tolerized T cells can form conjugates with APCs but are defective in immunological synapse formation.
J Immunol. 2005 Jul 15;175(2):829-38
PMID: 16002680
-
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.
Immunity. 1994 Jul;1(4):327-39
PMID: 7889419
-
Therapeutic potential of oral tolerance.
Nat Rev Immunol. 2004 Jun;4(6):407-19
PMID: 15173830
-
An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.
J Immunol. 2003 Aug 15;171(4):1961-8
PMID: 12902499
-
Murine CD1d-restricted T cell recognition of cellular lipids.
Immunity. 2000 Feb;12(2):211-21
PMID: 10714687
-
TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice.
J Immunol. 2004 Jan 15;172(2):834-42
PMID: 14707053
-
An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.
J Exp Med. 1994 Sep 1;180(3):1097-106
PMID: 7520467
-
CD1: presenting unusual antigens to unusual T lymphocytes.
Science. 1995 Jul 14;269(5221):185-6
PMID: 7542402
-
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Nat Med. 2001 Sep;7(9):1057-62
PMID: 11533711
-
Oral tolerance.
Transplantation. 1980 May;29(5):353-6
PMID: 6445612
-
CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells.
J Exp Med. 1998 Oct 19;188(8):1529-34
PMID: 9782130
-
Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.
Am J Pathol. 2005 Nov;167(5):1231-41
PMID: 16251408
-
The regulatory role of Valpha14 NKT cells in innate and acquired immune response.
Annu Rev Immunol. 2003;21:483-513
PMID: 12543936
-
Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver.
J Immunol. 2002 Mar 1;168(5):2188-99
PMID: 11859105
-
Modulating dendritic cells to optimize mucosal immunization protocols.
J Immunol. 1999 Oct 1;163(7):3668-75
PMID: 10490961
-
Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1.
J Immunol. 1997 Sep 1;159(5):2240-9
PMID: 9278312